The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Physicians and the Pharmaceutical Industry
Abstract
Context Controversy exists over the fact that physicians have regular contact with the pharmaceutical industry and its sales representatives, who spend a large sum of money each year promoting to them by way of gifts, free meals, travel subsidies, sponsored teachings, and symposia. Objective To identify the extent of and attitudes toward the relationship between physicians and the pharmaceutical industry and its representatives and its impact on the knowledge, attitudes, and behavior of physicians. Data Sources A MEDLINE search was conducted for English-language articles published from 1994 to present, with review of reference lists from retrieved articles; in addition, an Internet database was searched and 5 key informants were interviewed. Study Selection A total of 538 studies that provided data on any of the study questions were targeted for retrieval, 29 of which were included in the analysis. Data Extraction Data were extracted by 1 author. Articles using an analytic design were considered to be of higher methodological quality. Data Synthesis Physician interactions with pharmaceutical representatives were generally endorsed, began in medical school, and continued at a rate of about 4 times per month. Meetings with pharmaceutical representatives were associated with requests by physicians for adding the drugs to the hospital formulary and changes in prescribing practice. Drug company‐sponsored continuing medical education (CME) preferentially highlighted the sponsor’s drug(s) compared with other CME programs. Attending sponsored CME events and accepting funding for travel or lodging for educational symposia were associated with increased prescription rates of the sponsor’s medication. Attending presentations given by pharmaceutical representative speakers was also associated with nonrational prescribing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Conflict of Interest in the Debate over Calcium-Channel Antagonists
Stelfox, H. T., Chua, G., O'Rourke, K., & Detsky, A. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380206 · Cited by 615
Source of funding and outcome of clinical trials
Davidson, R. A. (1986) · Journal of General Internal Medicine · doi:10.1007/bf02602327 · Cited by 397
Cited by
Moore, D. A., Tetlock, P. E., Tanlu, L., & Bazerman, M. H. (2006) · Academy of Management Review · doi:10.5465/amr.2006.19379621 · Cited by 631
Non-clinical influences on clinical decision-making: a major challenge to evidence-based practice
Hajjaj, F., Salek, M., Basra, M., & Finlay, A. (2010) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2010.100104 · Cited by 360
Fluoroquinolone prescribing in the United States: 1995 to 2002
Linder, J. A., Huang, E. S., Steinman, M. A., Gonzales, R., & Stafford, R. S. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.09.015 · Cited by 308
Snyder, L., Leffler, C., & for the Ethics and Human Rights Committee, A. C. O. P. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00014 · Cited by 219
DESIGN AND REPORTING MODIFICATIONS IN INDUSTRY-SPONSORED COMPARATIVE PSYCHOPHARMACOLOGY TRIALS
SAFER, D. J. (2002) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200209000-00002 · Cited by 180
Metadata
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1990-04-15
- Volume
- 112
- Issue
- 8
- Pages
- 624-626
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1589140171
- Cited by
- 178
- References
- 2
- FWCI
- 9.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Physicians and the Pharmaceutical Industry. https://app.cochat.ai/papers/10.7326/0003-4819-112-8-624
- The paper
- Physicians and the Pharmaceutical Industry. (1990). Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-112-8-624
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.